2017. ISPOR European Congress – Cost of nivolumab in combination with ipilimumab as first line treatment in advanced melanoma across various European markets

Ovcinnikova O, Bourhis F, Shah MV, Potluri R, Chirita O, Sabater JF, et al. Cost of nivolumab in combination with ipilimumab as first line treatment in advanced melanoma across various European markets. Value Health. 2017 Oct-Nov;20(9):A426. Presented at: ISPOR 20th European Meeting: November 4-8, 2017; Glasgow, UK.